Introduction
============

Aberrant proliferation of vascular smooth muscle cells (VSMCs) contributes to the pathological change of vascular diseases such as hypertension, diabetic angiopathy and atherosclerosis ([@B28]; [@B9]; [@B2]). Previous studies have shown that the intracellular pH (pH~i~) is an important factor involved in the regulation of cell proliferation. Additionally, cell proliferation of multiple species is dependent on the pH~i~. Mitogen stimulation promotes cell cycle progression and ultimately proliferation. DNA, RNA and protein synthesis all require an alkaline pH~i~ ([@B31]; [@B14]).

To maintain pH~i~ homeostasis, cells utilize ionophores on the membrane to regulate the pH~i~ within a narrow physiological range ([@B5]; [@B3]; [@B6]). Those ionophores include channels, pumps, exchangers and cotransporters, all of which synergistically regulate the influx and outflux of H^+^/HCO~3~^-^ ions ([@B10]; [@B7]). Among them, the Na^+^-independent and electroneutral Cl^-^/HCO~3~^-^ exchanger (anion exchanger, AE) is encoded by the *SLC4* gene family, including *SLC4A1/AE1, SLC4A2/AE2*, and *SLC4A3/AE3*, which help regulate the pH~i~, cell volume and membrane potential of various cell types ([@B1]; [@B24]). Genome-wide association analysis showed that *AE2* exon deletion resulted in a loss of function of AE2 in osteoclast and cell alkalization, resulting in bone resorption lacunae disorder, the genetic cause of Angoras cattle and mouse osteopetrosis ([@B26]; [@B12]). Transforming growth factor beta 1 promotes fibroblast cell membrane AE2 expression and HCO~3~^-^ excretion, which can neutralize tumor microenvironment H^+^ ions to inhibit tumor cell invasion ([@B19]). [@B11] found that compared with wild-type mice, the pH~i~ of CD8^+^ T cells derived from *AE2* knockout mice is significantly increased, and CD8^+^ T cell proliferation and activation levels are obviously enhanced after CD3 stimulation.

[@B30] constructed a mouse AE2 model devoid of transmembrane domain cysteine (Cys) residues to investigate structure-function relationships for AE2. They found that extracellular pH was alkaline-shifted by a minimum of 0.6-0.7 pH units, and the anion exchange rate was significantly decreased in the absence of transmembrane domain Cys residues ([@B30]). Sulfur dioxide (SO~2~) was found to oxidize the -SH of Cys to -SOH, which changed the protein conformation and affected protein activity levels ([@B35]). We confirmed that SO~2~ suppressed the inflammatory response by sulphenylating NF-κB p65 at Cys^38^ in oleic acid-induced acute lung injury ([@B8]).

Recent studies have shown that aspartate aminotransferase can be catalyzed and produces SO~2~ in the metabolic pathway of sulfur-containing amino acids in mammalian organisms. Furthermore, SO~2~, which is considered the fourth gas signal molecule followed by NO, CO and H~2~S, plays an important role in the regulation of cardiovascular physiology and pathophysiology, such as vasodilation, inhibition of vascular calcification and inflammation, anti-oxidation and protection of the myocardium ([@B13]; [@B34]; [@B44]; [@B18]; [@B22]; [@B42]).

Therefore, we hypothesized that SO~2~ might activate the AE in VSMCs, thereby lowering the pH~i~ and further inhibiting VSMC proliferation. It has been reported that AE expression varies significantly among different tissues, and only *SLC4A2/AE2* mRNA expression is detected in the VSMC cell line A7r5 cells ([@B4]). Therefore, in this study, we aimed to determine whether SO~2~ impacts the pH~i~ and further inhibits the proliferation of VSMCs, as well as explore underlying molecular mechanisms.

Materials and Methods {#s1}
=====================

Chemicals and Drugs
-------------------

Sodium sulfite and sodium bisulfite (Na~2~SO~3~/NaHSO~3~), 4,4′- diisothiocyanatostilbene -2,20-disulfonic acid (DIDS) and H89 were purchased from Sigma-Aldrich (St. Louis, MO, United States). Nigericin (N1495) and Fluo 4-AM (F14217) were purchased from Invitrogen (Eugene, OR, United States), and BCECF/AM was purchased from Thermo Scientific (Waltham, MA, United States). Dithiothreitol (DTT) was purchased from Roche Diagnostics GmbH (Mannheim, Germany). Bay K8644 was purchased from selleck (Houston, TX, United States). SO~2~ donor was freshly prepared using Na~2~SO3/NaHSO~3~ dissolved in deionized water in 3:1 mole ratio. DIDS, H89, BCECF/AM and Fluo 4-AM were dissolved in DMSO. Nigericin was dissolved in ethanol.

Cells and Cell Culture
----------------------

A7r5 VSMCs were purchased from Kunming Cell Bank of Chinese Academy of Sciences (Kunming, China). Cell culture refers to previous literature ([@B23]). The cells were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum and 1% antibiotics (penicillin and streptomycin), and cells were placed in an incubator containing 5% CO~2~ at 37°C. To detect the pH~i~, cells were seeded in confocal dishes and experiments were performed once the cell density reached 90%.

Measurement of pH~i~ in VSMCs
-----------------------------

Measurement of pH~i~ was performed according to the literature ([@B21]; [@B15]). Fluorescent indicator BCECF/AM was used to monitor pH~i~ changes. Cells were washed twice with Krebs' bicarbonate buffer, followed by the incubation with Krebs' buffer containing 0.5 μM BCECF/AM for 30 min at room temperature. Loaded cells were washed twice with fresh Krebs' buffer to remove unbound dye and left at room temperature for another 30 min to allow the dye to be fully de-esterified in the cells. The pH~i~ was monitored using a confocal scanning laser microscope (Leica TCS SP8 MP FLIM, Mannheim, Baden-Württember, Germany). The fluorescence intensity was measured at an excitation wavelength of 405 and 496 nm, and an emission wavelength of 535 nm was recorded. The fluorescence intensity ratio (F496/F405) was used to evaluate the pH~i~. pH~i~ image analysis was performed using LAF-AS software (Leica). The Krebs' buffer was prepared as follows (mM): 118 NaCl, 5.4 KCl, 1.3 CaCl~2~, 1.2 MgSO~4~, 1.2 KH~2~PO~4~, 25 NaHCO~3~ and 11.7 glucose, and the pH was adjusted to 7.4 with NaOH. During the measurement of pH~i~, drugs were added directly to the buffer and the fluorescence intensity was recorded. A high KCl solution (130 mM KCl, 10 mM Hepes buffer, pH 6.3--9.1) was prepared, and H^+^ was equilibrated with 20 μM cation ionophore nigericin to prepare a fluorescence intensity-pH~i~ standard curve ([Supplementary Figure S1](#SM1){ref-type="supplementary-material"}). The different concentrations of SO~2~ in the study of pH~i~ were grouped into control, SO~2~ (50 μM), SO~2~ (100 μM), and SO~2~ (200 μM). The change of pH~i~ was calculated as the difference in pH~i~ between the starting time point of SO~2~ treatment and 9 min after SO~2~ treatment.

Determination of AE Activity in VSMCs
-------------------------------------

AE activity was measured according to the method described in the previous literature ([@B32]; [@B39]; [@B21]). In brief, the activity of AE in A7r5 cells was evaluated by detecting the recovery rate of cells from an intracellular alkalinization. Cells were loaded with BCECF/AM as previously described. The Hepes buffer solution was prepared as follows (mM): 150 NaCl, 5.4 KCl, 2 CaCl~2~, 1 MgCl~2~, 5 Hepes and 10 glucose, adjusted to pH 7.4 with NaOH. At the first min, 20 mM NH~4~Cl was quickly added to the buffer. Once the cells were exposed to NH~4~Cl, NH~3~ rapidly diffused into the cells and combined with intracellular H^+^ to form NH~4~^+^, leading to rapid intracellular alkalinization. The pH~i~ gradually decreases from the alkaline peak as HCO~3~^-^ ions efflux during AE stimulation. The rate at which the pH~i~ returns within the first minute (ΔpH/min) represents AE activity. For the SO~2~ and the AE activation experiment, the groups were divided as follows: control, SO~2~ (100 μM) and SO~2~ (200 μM), and SO~2~ donor administrated 10 min before pH~i~ measurement. To verify that SO~2~ stimulated AE via sulphenylation of AE2, we divided the groups as follows: control, SO~2~, SO~2~ + DTT or PDGF-BB, PDGF-BB + SO~2~ and PDGF-BB + SO~2~ + DTT. One hour before the pH~i~ measurement, cells were treated with 50 ng/ml PDGF-BB, and 50 min before pH~i~ measurement, cells were pretreated with 200 μM SO~2~ and / or 0.4 mM DTT.

Western Blotting
----------------

Vascular smooth muscle cells were seeded in six-well plates and upon a cell density of 60--70%, were synchronized with DMEM containing 0.5% FBS for 24 h.

To confirm that AE was involved in the process of SO~2~ inhibition of PDGF-BB-induced VSMC proliferation, cell were either (1) untreated; (2) treated with 50 ng/ml PDGF-BBC for 24 h; (3) pretreated with 200 μM SO~2~ donor for 30 min, then 50 ng/ml PDGF-BB for 24 h; (4) treated with 200 μM SO~2~ donor for 30 min; (5) treated with 50 ng/ml PDGF-BB and 30 μM DIDS for 24 h; and (6) pretreated with 200 μM SO~2~ donor for 30 min, then 50 ng/ml PDGF-BB and 30 μM DIDS for 24 h.

To measure the phosphorylation level of PKA by SO~2~, cells were either (1) untreated; (2) treated with 20 μM H89 for 30 min; (3) pretreated with 20 μM H89 for 30 min, and 200 μM SO~2~ donor for 10 min; or (4) treated with 200 μM SO~2~ donor for 10 min.

All cells were collected and lysed in lysis buffer (50 mM Tris-HCl \[pH 7.4\], 150 mM NaCl, 1 mM EDTA, 1% NP40, 0.25% sodium deoxycholate, 1 mM PMSF, protease and phosphatase inhibitors) for 20 min at 4°C. They were then centrifuged at 12000 rpm for 10 min at 4°C, and 2x denatured protein loading buffer was added to the supernatant. The mixture was boiled at 100°C for 10 min and cooled at room temperature. Equal amounts of protein (30--60 μg) were run on an 8--10% SDS-PAGE gel. After protein separation, they were transferred to nitrocellulose membranes. The primary antibody dilutions were: 1:1000 for both PKA and p-PKA, and 1:500 for Ki67.

Measurement of VSMC Proliferation With Cell Counting Kit-8 (CCK8)
-----------------------------------------------------------------

Cell proliferation was measured according to the reference ([@B23]). By using a CCK-8 kit, A7r5 cells were first seeded in 96-well plates at 2 × 10^3^ cells / well, and divided into seven groups: (1) blank control (cell-free medium); (2) control (cell-containing medium); (3) treated with 50 ng/ml PDGF-BBC for 24 h; (4) pretreated with 200 μM SO~2~ donor for 30 min, then 50 ng/ml PDGF-BB for 24 h; (5) treated with 200 μM SO~2~ donor for 30 min; (6) treated with 50 ng/ml PDGF-BB and 30 μM DIDS for 24 h; and (7) pretreated with 200 μM SO~2~ donor for 30 min, then 50 ng/ml PDGF-BB and 30 μM DIDS for 24 h. Ten μl of CCK8 reagent was added into a 100 μl- medium, and incubated at 37°C for 4 h. The absorbance was measured at 450 nm using a microplate reader. The mean absorbance value of the blank control group was subtracted from each group as the corrected absorbance of each group.

Measurement of AE2 Sulphenylation in VSMCs
------------------------------------------

Sulphenic acid modification of AE2 was measured as described previously ([@B8]). The cells were divided into three groups: untreated, treated with 200 μM SO~2~ donor for 10 min, or simultaneously with SO~2~ donor and 0.4 mM DTT for 10 min. Cells were pretreated with 50 ng/ml PDGF-BB for 1 h to induce cell proliferation. DAz-2 is a specific sulphenic acid probe used to label proteins modified by sulphenic acid. The cells were lysed with non-denaturing lysis buffer containing 5 mM DAz-2 and centrifuged at 16000 *g* for 4 min at 4°C. The supernatant was divided into two parts. 10 μl was used as total protein, which was added to denatured protein loading buffer and boiled for 10 min at 100°C. The remaining supernatant was incubated at 37°C for 2 h with gentle shaking to extract the sulphenic acid modified protein. The mixture was then incubated with 250 μM p-biotin for 2 h at 37°C with gentle shaking to label the protein with biotin. Biotinylated proteins were precipitated with UltraLinkTM Immobilized NeutrAvidinTM (Thermo Fisher Scientific, Waltham, MA, United States) and incubated for 4 h on a shaker at 4°C. The beads were washed three times with PBS, and non-denatured protein loading buffer was added and boiled at 100°C for 10 min. Total protein and sulphenic acid modified protein were subjected to WB analysis. The primary antibody for AE2 was diluted 1:500. The secondary antibody was diluted 1:2000.

Imaging the Intracellular Calcium in VSMCs
------------------------------------------

The intracellular calcium in VSMCs was imaged with fluorescent calcium probe, Fluo 4-AM. A7r5 cells were divided into four groups: PDGF-BB, PDGF-BB + SO~2~, PDGF-BB + Bay K8644, and PDGF-BB + Bay K8644 + SO~2~. Cells were incubated with 50 ng/ml PDGF-BB for 1 h, 1 μM Bay K8644, an L-type calcium channel agonist, for 30 min, and 200 μM SO~2~ for 10 min. After the treatment, the cells were washed with Krebs' buffer for twice and incubated with 5 μM Fluo 4-AM in the dark for 30 min at 37°C. The unincorporated dye was removed by washing the cells twice. Loaded cells were maintained at room temperature for another 30 min to allow Fluo 4-AM to de-esterify. Fluorescence image was obtained using a laser scanning confocal microscope (Olympus), at appropriate wavelength settings (excitation at 488 nm and emission at 520 nm).

Statistical Analysis
--------------------

Data were processed using SPSS 17.0 software (SPSS Inc, Chicago, IL, United States). All data were expressed as mean ± standard error. To examine the effect of SO~2~ on AE, a *t*-test was performed to compare the difference between control and DIDS. To examine the effect of different concentrations of SO~2~ on AE, PKA phosphorylation and A7r5 cell proliferation, comparisons of three or more groups were analyzed by ANOVA, and the Bonferroni test or the Dunnett T3 test were used to compare the difference between two groups. *p* \< 0.05 was considered statistically significant.

Results
=======

SO~2~ Reduced pH~i~ in VSMCs
----------------------------

By real-time monitoring of the pH~i~ with the fluorescent probe, we found that the SO~2~ donor at the concentrations of 50, 100, and 200 μM decreased the pH~i~ in VSMCs by 0.120 ± 0.012, 0.134 ± 0.011, and 0.200 ± 0.020, respectively (all *p* \< 0.01, [Figure 1A,B](#F1){ref-type="fig"}).

![SO~2~ decreased the pH~i~ in VSMCs. **(A)** Representative tracing showing 200 μM SO~2~ donor. **(B)** Effect of SO~2~ donor on pH~i~ (*n* = 16--33). ^∗∗^*p* \< 0.01 compared with pH~i~ before SO~2~ donor application.](fphar-10-00313-g001){#F1}

SO~2~ Activated AE to Reduce pH~i~ in VSMCs
-------------------------------------------

Anion exchanger is the main acid loader of VSMCs, which pumps out one HCO~3~^-^ in exchange for one Cl^-^ into the cells, maintaining intracellular Cl^-^ concentration and lowering the pH~i~. To further validate the effect of SO~2~ on the AE, we tested the activity of the AE in VSMCs by using the widely accepted NH~4~Cl perfusion method. As shown in [Figure 2A,B](#F2){ref-type="fig"}, the SO~2~ donor at varying concentrations of 100 and 200 μM activated the AE in VSMCs (*p* \< 0.05 and *p* \< 0.01, respectively).

![Effect of SO~2~ on AE activity. **(A)** Representative tracings of the rapid alkalinization of 20 mM NH~4~Cl and recovery from higher pH~i~ at different concentrations. SO~2~ was given 10 min before measurement. **(B)** Results were shown in mean ± SEM (*n* = 25--39). ^∗^*p* \< 0.05, ^∗∗^*p* \< 0.01 compared with control.](fphar-10-00313-g002){#F2}

Pretreatment with 30 μM DIDS, a Cl^-^/HCO~3~^-^ exchanger inhibitor, for 20 min significantly attenuated the pH~i~ reduction caused by SO~2~ (*p* \< 0.01, [Figure 3A,B](#F3){ref-type="fig"}), suggesting that SO~2~ donor reduced pH~i~ by activating the AE in VSMCs.

![Effect of SO~2~ on pH~i~ in the presence or absence of DIDS in VSMCs. **(A)** Representative tracings of 200 μM SO~2~ donor alone (*n* = 19) and in the presence of 30 μM DIDS (*n* = 19). **(B)** Results were shown in mean ± SEM. ^∗∗^*p* \< 0.01 compared with control.](fphar-10-00313-g003){#F3}

SO~2~ Activated AE by Sulphenylating AE2 in VSMCs
-------------------------------------------------

To investigate the mechanism by which SO~2~ activates AE activity in VSMCs, we tested whether SO~2~ oxidizes Cys of AE2 by AE2 sulphenylation. As shown in [Figure 4A,B](#F4){ref-type="fig"}, SO~2~ promoted AE2 sulphenylation and AE activation (*p* \< 0.05, *p* \< 0.01, respectively), and reduced pH~i~ (*p* \< 0.05). Addition of 0.4 mM DTT, a thiol reductant, reversed SO~2~-induced AE2 sulphenylation and activation of the AE (both *p* \< 0.05), restoring SO~2~-induced pH~i~ reduction in VSMCs as well (*p* \< 0.01, [Figure 4C](#F4){ref-type="fig"}). This suggests that the thiol group is a likely target of SO~2~ for activation of the AE in VSMCs.

![Mechanisms by which SO~2~ donor activated AE. **(A)** Sulphenylation of AE2 by 200 μM SO~2~, and 0.4 mM DTT reversed the process. SO~2~ and DTT were given 10 min before collecting cells (*n* = 6). **(B)** Representative tracings of AE activity in the absence or presence of 200 μM SO~2~ donor and 0.4 mM DTT. Results were shown as mean ± SEM (*n* = 25--39). **(C)** The change of pHi in VSMCs in each group. **(D)** Effect of SO~2~ donor on PKA phosphorylation. Cells were pretreated with H89 30 min, followed by SO~2~ donor in 10 min (*n* = 6). ^∗^*p* \< 0.05, ^∗∗^*p* \< 0.01, n.s.*p* \> 0.05.](fphar-10-00313-g004){#F4}

We also aimed to understand if SO~2~ affects the pH~i~ by activation of PKA and further activation of the exchanger in VSMCs. As shown in [Figure 4D](#F4){ref-type="fig"}, SO~2~ (200 μM) did not stimulate PKA within 10 min in VSMCs (*p* \> 0.05). The results suggested that the PKA pathway did not mediate pH~i~ reduction by SO~2~ in an acute phase.

SO~2~ Inhibited VSMC Proliferation Depending on AE Activation
-------------------------------------------------------------

To further elucidate if SO~2~ inhibit VSMC proliferation depending on AE activation, we constructed a PDGF-BB-induced VSMC proliferation cell model. In VSMCs pretreated with PDGF-BB and treated with SO~2~, levels of AE2 sulphenylation and AE activity were significantly increased (*p* \< 0.05, *p* \< 0.01, respectively, [Figure 5A,B](#F5){ref-type="fig"}) and the pH~i~ was significantly reduced (*p* \< 0.05, [Figure 5C](#F5){ref-type="fig"}). VSMC proliferation evaluated by Ki67 protein expression and CCK8 activity was significantly inhibited by SO~2~ (*p* \< 0.05, *p* \< 0.01, respectively, [Figure 5D,E](#F5){ref-type="fig"}), as compared with those in VSMCs pretreated with PDGF-BB only. However, SO~2~ failed to inhibit PDGF-BB-induced VSMCs proliferation once AE was inhibited by DIDS (both *p* \> 0.05, [Figure 5D,E](#F5){ref-type="fig"}).

![Activation of AE was responsible for SO~2~ to inhibit VSMC proliferation. **(A)** Sulphenylation of AE2 by SO~2~ in the presence of PDGF-BB. Cells were pretreated with 50 ng/ml PDGF-BB 1 h, followed by 200 μM SO~2~ and 0.4 mM DTT 10 min (*n* = 6). **(B)** Representative tracings of AE activity in the absence or presence of 200 μM SO~2~ donor and 0.4 mM DTT when cells were pretreated with 50 ng/ml PDGF-BB 1 h (*n* = 31--39). **(C)** pH~i~ change in each group. **(D,E)** WB and CCK8 were used to measure the proliferation of VSMCs. 50 ng/ml PDGF-BB, 200 μM SO~2~ and 30 μM DIDS were administered for 24 h (*n* = 6). ^∗^*p* \< 0.05, ^∗∗^*p* \< 0.01, n.s.*p* \> 0.05.](fphar-10-00313-g005){#F5}

SO~2~ Reduced the Intracellular Calcium by Inhibiting L-Type Calcium Channel in VSMCs
-------------------------------------------------------------------------------------

To investigate the effects of SO~2~ on intracellular calcium in VSMCs, we used Fluo 4-AM to image the intracellular calcium in VSMCs. The results showed that SO~2~ reduced PDGF-stimulated intracellular calcium in VSMCs. While, Bay K8644, an L-type calcium channel agonist, blocked SO~2~-reduced intracellular calcium content in PDGF-stimulated VSMCs ([Figure 6](#F6){ref-type="fig"}). The results indicated that SO~2~ might decrease the calcium level by inhibiting L-type calcium channel in VSMCs.

![SO~2~ decreased the intracellular calcium level by inhibiting L-type calcium channel in VSMCs. Cells were incubated with 50 ng/ml PDGF-BB for 1 h, 1 μM Bay K8644 for 30 min and 200 μM SO~2~ for 10 min. Fluorescence intensity represents calcium levels.](fphar-10-00313-g006){#F6}

Discussion
==========

As well known, pH~i~ is precisely controlled and needs to be maintained within physiological range. The imbalance of pH~i~ is an important pathological basis for the abnormal cell metabolism and life activities. Therefore, pH~i~ is a vital target for clinical treatment of diseases. In the present study, we firstly reported that SO~2~ donor decreased the pH~i~ of VSMCs by enhancing AE2 sulphenylation to activate the AE, which might partially mediate the inhibitory effect of SO~2~ on VSMC proliferation.

At first, by monitoring pH~i~ in real time, we found that the treatment of 50 ∼ 200 μM SO~2~ donor for 9 min decreased pH~i~ in VSMCs by 1.7--2.8%, respectively. The mechanisms by which SO~2~ reduced pH~i~ in VSMCs, however, have yet been unclear. AE is the main acid loader in VSMCs and plays an important role in the regulation of pH~i~ ([@B36]). Previous studies reported that pH~i~ was increased significantly when NH~4~Cl loaded cells, and consequently AE was activated to extrude HCO~3~^-^, which eventually restored the pH~i~ to normal levels ([@B39]; [@B21]). Therefore, we directly detected the activity of AE using NH~4~Cl stimulation as previously reported ([@B32]). The data showed that SO~2~ donor markedly steepened the recovery slope of pH~i~ trace following the pH~i~ peak due to NH~4~^+^-induced alkalinization, suggesting that SO~2~ activated AE in VSMCs as we expected. Subsequently, the fact that an inhibitor of Cl^-^/HCO~3~^-^ exchanger, DIDS blunted the SO~2~-induced decrease in pH~i~ in VSMCs supported the speculation that the activation of AE was involved in the effect of SO~2~ on the pH~i~ in VSMCs.

However, up to now, the mechanisms by which SO~2~ activated the AE in VSMCs remain unclear. Cysteine thiol group (-SH) can be oxidized to sulphenic acids (-SOH) and the process is termed as protein sulphenylation, which is an important mechanism for regulating protein function. [@B17] found that sulphenylation of inositol-requiring enzyme 1 could inhibit endoplasmic reticulum stress and activate antioxidant response. The sulphenylation of NF-κB p65 by SO~2~ resulted in an inactivation of NF-κB pathway ([@B8]). While Cys residues mutation within transmembrane domain of AE2 could affect the activity of AE2 ([@B30]). Interestingly, our data showed that SO~2~ sulphenylated AE2 in VSMCs in association with the enhancement of the activity of AE. While, a thiol reductant DTT blocked the effect of SO~2~ on sulphenylation and the activity of AE2. Moreover, PKA pathway was also reported to participate the activation of AE ([@B29]) and SO~2~ treatment for 30 min activated cAMP/PKA pathway ([@B23]). But, in the present study, SO~2~ incubation for 9 min could not enhance the phosphorylation of PKA, which excluded the possibility that SO~2~ indirectly promoted the activation of AE via PKA pathway. Those above results suggested that SO~2~ might directly activate the AE by inducing the sulphenylation of AE2 at the posttranslational level.

To investigate the significance of SO~2~-induced reduction of pH~i~ in VSMCs in its inhibitory effect on VSMC proliferation, DIDS was used to block the SO~2~-induced reduction of pH~i~ in VSMCs, and then Ki67 expression and CCK8 activity were analyzed as the markers of VSMC proliferation. We found that SO~2~ inhibited PDGF-BB-induced VSMC proliferation, while DIDS abolished the inhibitory effect of SO~2~ on PDGF-BB-induced VSMC proliferation, which suggested that SO~2~ inhibited VSMC proliferation at least partly through decreasing pH~i~ in VSMCs.

However, we also found an interesting detached phenomenon that SO~2~ donor alone did not inhibit the proliferation of VSMC but inhibited PDGF-BB-induced VSMC proliferation. In fact, under physiological condition, VSMC-derived endogenous SO~2~ was sufficient enough to inhibit cell proliferation. Therefore, the supplement of additional exogenous SO~2~ donor to the VSMC on the basis of sufficient endogenous SO~2~ level would not further exert the anti-proliferative effect ([@B23]). However, under certain pathophysiological conditions, when VSMCs were insulted by the exogenous injury stimuli, endogenous SO~2~ production was decreased and the anti-proliferative effect was weakened, resulting to the excessive cell proliferation. In such a case, the supplement of SO~2~ donor, on the basis of the deficient endogenous SO~2~ level, would exert a markedly anti-proliferative effect on the proliferating VSMC ([@B34]; [@B23]; [@B38]; [@B43]). In brief, this discrepancy effect of SO~2~ donor on the VSMC proliferation on the different conditions might provide a novel idea for the treatment of vascular remodeling in vascular-injury diseases.

In addition to pH~i~, Ca^2+^ mobilization is another important stimulus for cell migration and proliferation ([@B40]; [@B25]). Endogenous SO~2~ and its derivates could inhibit L-type calcium channel, which might help explain the mechanism of vasorelaxant function ([@B13]). Therefore, we observed the effect of SO~2~ on the L-type calcium channel. The data showed that 200 μM SO~2~ could inhibit the PDGF-BB-stimulated increase in the cytosolic Ca^2+^ concentration in VSMCs. However, pretreatment of Bay K8644, a specific activator of L-type calcium channel, could block the inhibitory effect of SO~2~ on the cytosolic Ca^2+^ concentration, suggesting that L-type calcium channel inhibition occurs under experimental conditions in the presence of SO~2~ donor.

However, our study still has some limitation. For example, we studied the effect of SO~2~ on pH~i~ only in cultured VSMCs, but whether the phenomenon occurs in the complex vascular wall is still unknown. As we all know, vascular wall is composed of complex multicellular tissue. It needs to respond to various stimuli such as mechanical stress and neurological and humoral factors in a coordinate manner. The intercellular communication among the constituent cells of vessel wall plays an important role in the regulation of vascular structure and activity and is indispensable for the synchronous response by the wall of vessels. The gap junction was found to exert the abovementioned function of intercellular communication ([@B16]; [@B33]; [@B41]). The gap junction is composed of a kind of transmembrane proteins termed connexin and form a direct conduit for the exchanges of intercellular signals such as ions and bioactive metabolites, which allows vessel cells to sense the functional and metabolic state of neighbor cells and rapidly modulate the activity by themselves, and therefore synchronously respond to the stimuli ([@B16]; [@B33]; [@B41]). In addition to the gap junction, gasotransmitters also participate the intercellular communication. Since 1980s, endothelial nitric oxide as the first gasotransmitter was found to regulate the VSMC relaxation via a paracrine pathway, which is partly due to its unique properties including small molecular weight, rapid transmembrane diffusion and extensive action ([@B37]; [@B18]; [@B20]; [@B27]). In the previous study, pulmonary artery smooth muscle cell-derived SO~2~ was found to inhibit the collagen accumulation in the pulmonary artery fibroblasts ([@B43]). Therefore, we speculated that SO~2~ might act as an intercellular signal molecule to transduce the massagers among the constitute cells in the vessels, which participated in the synchronicity of vascular function. However, more experiments are needed to extend the effect of SO~2~ on single channel activity to complex vascular wall.

Conclusion
==========

We discovered the effect of SO~2~ on pH~i~ of VSMCs and clarified the mechanism by which SO~2~ decreased pH~i~ of VSMCs. Most importantly, we demonstrated that SO~2~-induced decrease in pH~i~ of VSMCs might participate the inhibitory effect of SO~2~ donor on the VSMC proliferation stimulated by mitogen such as PDGF-BB. We expect that those interesting results maybe provide a new idea for the potential clinical prevention and treatment of vascular remodeling in vascular injury diseases such as hypertension.
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